Skip to main content

Table 4 Best Objective Response

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Response # of Patients (%) (n = 90 evaluable) 95% C. I.
Complete 10 (11%) 5.5 – 19.5
Partial 18 (20%) 12.3 – 29.8
Complete/Partial 28 (31%) 21.8 – 41.7
Stable Disease 33 (37%) 26.8 – 47.5
Progressive Disease 29 (32%) 22.8 – 42.9